Department of Obstetrics and Gynaecology, Gelre Hospital, Apeldoorn, The Netherlands.
Division of Haemostasis and Thrombosis, Department of Haematology, Erasmus Medical Centre, University of Rotterdam, Rotterdam, The Netherlands.
Haemophilia. 2018 Nov;24(6):950-956. doi: 10.1111/hae.13552. Epub 2018 Jul 10.
To explore key factors for successful support in women with moderate or severe Von Willebrand disease (VWD) who are faced with heavy menstrual bleeding (HMB) and surgery.
A qualitative study design with focus-group interviews and thematic analysis of the discussions.
Eleven VWD women aged 41-68 years (median age 58 years) who had had a hysterectomy or bipolar radiofrequency ablation (BRA) because of HMB participated in this study. Three of the 11 participants had VWD diagnosed before surgery. Two focus groups were conducted in the summer of 2012. Patients were identified through participation in a nationwide study on Von Willebrand disease in the Netherlands (WiN study). Inclusion criteria were at least 18 years of age, fluent in Dutch, diagnosed with VWD (based on Von Willebrand factor (VWF) antigen and/or activity levels < 30 IU/dL) and previous surgical therapy for HMB.
The following key factors were identified during focus-group interviews: receiving information, proactive support from providers and considering bleeding disorders as a cause of HMB. Other topics were as follows: experiences with VWD and/or surgery, how relieved patients were when menses stopped, patients hoped that in future, providers would work better together so that women receive the best care.
In this focus-group study among women with VWD who underwent surgery because of HMB, support by professionals could be improved by considering a bleeding disorder in women with HMB, providing information about different types of surgery and shared decision-making regarding type of interventions.
探讨中度或重度血管性血友病(VWD)女性在面临月经过多(HMB)和手术时获得成功支持的关键因素。
采用焦点小组访谈和主题分析的定性研究设计。
11 名年龄 41-68 岁(中位年龄 58 岁)的 VWD 女性参与了这项研究,她们因 HMB 而行子宫切除术或双极射频消融术(BRA)。11 名参与者中有 3 名在手术前被诊断为 VWD。2 个焦点小组于 2012 年夏天进行。患者是通过参与荷兰全国性的血管性血友病研究(WiN 研究)确定的。纳入标准为年龄至少 18 岁,能流利地使用荷兰语,根据血管性血友病因子(VWF)抗原和/或活性水平<30IU/dL 被诊断为 VWD,并接受过 HMB 的手术治疗。
在焦点小组访谈中确定了以下关键因素:接受信息、提供者的积极支持以及将出血障碍视为 HMB 的原因。其他主题包括:VWD 和/或手术的经历、患者在月经停止时的缓解程度、患者希望在未来,提供者能够更好地合作,以便女性获得最佳护理。
在这项针对因 HMB 而行手术的 VWD 女性的焦点小组研究中,通过考虑 HMB 女性的出血障碍、提供不同类型手术的信息以及针对干预类型的共同决策,可以改善专业人员的支持。